Results 281 to 290 of about 80,269 (322)

Correction: Case Report: Fecal microbiota transplantation via capsules ameliorated clinical outcomes in a patient with multiple sclerosis. [PDF]

Front Immunol
Bibbò S, De Maio F, Capone F, Quaranta G, Rondinella D, Rosato R, Minelli M, De Lorenzis D, Sanguinetti M, Cammarota G, Di Lazzaro V, Masucci L.   +11 more
europepmc   +1 more source

Identification of key gut microbiota and microbial QTL in contributing to the significant differences in body weight between two Chinese local chicken breeds

Animal Genetics, Volume 57, Issue 1, February 2026.
Abstract Previous studies have identified genetic loci that are associated with both feed conversion efficiency and gut microbiota in chickens, suggesting that interactions between the host genome and gut microbiota may influence chicken growth. However, the number of microbial QTL and gut microbiota associated with chicken body weight remains largely ...
Linna Zhang, Chenglong Wang, Xiaojian Zhang, Guohui Li, Zheya Sheng   +4 more
wiley   +1 more source

Aberrant Growth in 5‐Year‐Old Children After Antibiotics in the First Week of Life

Acta Paediatrica, Volume 115, Issue 2, Page 309-318, February 2026.
ABSTRACT Aim We examined the relationship between early‐life antibiotics, different regimens, and growth until age five years. Methods Data from two parallel birth cohorts were analysed: 128 healthy term‐born children and 147 term‐born children who received antibiotics for suspected neonatal sepsis, randomised across three regimens: Amoxicillin ...
Lisanne M. van Leeuwen, Gina J. van Beveren, Marieke A. G. Peeters, Dennis Souverein, Sjoerd Euser, Debby Bogaert, Marlies A. van Houten   +6 more
wiley   +1 more source

Targeting Gut-Lung Crosstalk in Acute Respiratory Distress Syndrome: Exploring the Therapeutic Potential of Fecal Microbiota Transplantation. [PDF]

Pathogens
Ziaka M.
europepmc   +1 more source

Alterations in Gut Microbiota and Metabolism in Cirrhotic Portal Hypertension: Implications for Disease Progression

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 4, Page 538-556, February 2026.
In‐depth multiomics analyses revealed that the gut microbiota in patients with CPH is dysbiotic. Altered gut microbiota plays an important role in the progression of CPH and affects the host's arginine metabolism to promote arginine biosynthesis. The pro‐inflammatory effects of certain gut bacteria induce iNOS expression, which together act on the ...
Qun Zhang, Jinghua Cui, Yixin Hou, Lining Guo, Hai Li, Guiqin Zhou, Xiaojing Wang, Bingbing Zhu, Ke Shi, Yi Zhang, Yufei Bi, Yanqiu Li, Lina Sun, Ying Feng, Jing Yuan, Xianbo Wang   +15 more
wiley   +1 more source

Effect of fecal microbiota transplantation on “intestinal flora-SCFAs-GPR43 - gastrointestinal peptide” pathway in rats with high-fat diet [PDF]

Yu He, Lijun Cui, Xiaomei Wang, Xu Wang, Shaoyang Liu, Chen Bai, Jianhua Zhen, Tiegang Liu, Xiaohong Gu   +8 more
openalex   +1 more source

Health economic evaluations of fecal microbiota transplantation for non-clostridioides difficile related diseases: a systematic review. [PDF]

Health Econ Rev
Wei Q, Wang Y, Rui M, You JHS.
europepmc   +1 more source

Rapid risk assessment on acute reference dose (ARfD) of cereulide in infants and information on acute consumption of infant formulae

EFSA Journal, Volume 24, Issue 2, February 2026.
Abstract EFSA has received a request for a rapid risk assessment for cereulide from the European Commission. Cereulide is a heat‐stable emetic toxin produced by Bacillus cereus, recently detected in infant formulae from multiple manufacturers. This led to precautionary recalls across several countries.
European Food Safety Authority (EFSA), Chantra Eskes, José Cortiñas‐Abrahantes, Bernard Bottex, Jean‐Lou C. M. Dorne, Bruno Dujardin, Rita Ferreira de Souza, Zsuzsanna Horvath, Eirini Kouloura, Luisa Ramos Bordajandi, Valentina Rizzi, Hans Steinkellner, Mary Gilsenan   +12 more
wiley   +1 more source

Case Report: Fecal microbiota transplantation via capsules ameliorated clinical outcomes in a patient with multiple sclerosis. [PDF]

Front Immunol
Bibbò S, De Maio F, Capone F, Quaranta G, Rondinella D, Rosato R, Minelli M, De Lorenzis D, Sanguinetti M, Cammarota G, Di Lazzaro V, Masucci L.   +11 more
europepmc   +1 more source

Defining the Intestinal eCBome and Oxylipin Signaling Systems in a TDP‐43 Mouse Model of Frontotemporal Dementia

The FASEB Journal, Volume 40, Issue 2, 31 January 2026.
TDP‐43 overexpressing mice, a genetic model of frontotemporal dementia, exhibit dramatic changes in their small intestinal endocannabinoidome members, in terms of both altered concentrations of lipid mediators and expression of some of their receptors (Cnr1, Gpr119, Gpr55, Pparg) and metabolic enzymes (Napepld, Faah). Also, the levels of some oxylipins
Hayatte‐Dounia Mir, Giada Giorgini, Irene Santos‐García, Elizabeth Dumais, Carmen Rodríguez‐Cueto, Eva de Lago, Cristoforo Silvestri, Nicolas Flamand, Javier Fernández‐Ruiz, Vincenzo Di Marzo   +9 more
wiley   +1 more source